twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2005
vol. 107
 
Share:
Share:
abstract:
Original paper

Gy­ra­te ­atro­phy­ of ­the­ cho­ro­id ­and­ re­ti­na­ in­ chil­dren

Bro­nis­ła­wa­ Ko­ra­szew­ska­-M­at­usze­wska
1
,
Małgorzata Korzekwa
1
,
Elżbieta Samochowiec-Donocik
1

  1. Katedra i Klinika Okulistyki Dziecięcej Śląskiej Akademii Medycznej w Katowicach
Klinika Oczna 2005, 107(1-3): 121-123
Online publish date: 2005/03/15
View full text Get citation
 
Introduction
the history and clinical findings of 3.5 and 5.5-years old siblings with gyrate atrophy (GA) of the choroid and retina are presented.

Material and methods
Siblings: a girl at the age 3.5 years and her brother 5.5 years were examined. Clinical and biochemical findings were performed.

Results
he best corrected visual acuity of both girl and boy was below normal values. Myopia of middle degree and myopic astigmatism was presented in both eyes of siblings. On fundus examination sharply defined bizarre shaped atrophic areas of peripheral choroid and retina were seen in both eyes of children. Fluorescein angiography showed hyperfluorescence in the area of gyrate atrophy. The boy’s plasma ornithine level was increased to 974.950 umol/L and the girl’s to 1007.188 umol/L. The concentration of ornithine, lysine and arginine in the urea of these patients was high.

Conclusions
Early cilnical and biochemical diagnosis of gyrate atrophy of the choroid and retina in children is very important, because low protein diet with elimination of arginine can reduce the progression of this severe disease.

keywords:

gyrate atrophy of choroid, retina, hyperornithinemia, children, siblings

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.